全文获取类型
收费全文 | 9792篇 |
免费 | 694篇 |
国内免费 | 11篇 |
专业分类
耳鼻咽喉 | 118篇 |
儿科学 | 361篇 |
妇产科学 | 280篇 |
基础医学 | 1341篇 |
口腔科学 | 251篇 |
临床医学 | 1387篇 |
内科学 | 1680篇 |
皮肤病学 | 148篇 |
神经病学 | 942篇 |
特种医学 | 287篇 |
外科学 | 977篇 |
综合类 | 94篇 |
一般理论 | 4篇 |
预防医学 | 1187篇 |
眼科学 | 99篇 |
药学 | 669篇 |
中国医学 | 3篇 |
肿瘤学 | 669篇 |
出版年
2021年 | 146篇 |
2020年 | 88篇 |
2019年 | 155篇 |
2018年 | 157篇 |
2017年 | 134篇 |
2016年 | 141篇 |
2015年 | 146篇 |
2014年 | 256篇 |
2013年 | 396篇 |
2012年 | 514篇 |
2011年 | 615篇 |
2010年 | 276篇 |
2009年 | 239篇 |
2008年 | 455篇 |
2007年 | 563篇 |
2006年 | 512篇 |
2005年 | 501篇 |
2004年 | 469篇 |
2003年 | 449篇 |
2002年 | 493篇 |
2001年 | 256篇 |
2000年 | 265篇 |
1999年 | 200篇 |
1998年 | 136篇 |
1997年 | 119篇 |
1996年 | 93篇 |
1995年 | 98篇 |
1994年 | 90篇 |
1993年 | 80篇 |
1992年 | 187篇 |
1991年 | 176篇 |
1990年 | 162篇 |
1989年 | 144篇 |
1988年 | 142篇 |
1987年 | 137篇 |
1986年 | 123篇 |
1985年 | 140篇 |
1984年 | 96篇 |
1983年 | 78篇 |
1982年 | 80篇 |
1981年 | 89篇 |
1980年 | 54篇 |
1979年 | 94篇 |
1978年 | 72篇 |
1977年 | 56篇 |
1976年 | 65篇 |
1975年 | 54篇 |
1973年 | 55篇 |
1972年 | 57篇 |
1970年 | 56篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
3.
Gary E. Stapleton Benjamin W. Eidem Ricardo H. Pignatelli Karina M. Carlson Charles E. Mullins Ronald G. Grifka 《Congenital heart disease》2006,1(3):116-119
Background. A persistent patent ductus arteriosus (PDA) may delay closure of a coexisting atrial septal defect (ASD) due to volume loading and enlargement of the left atrium. The purpose of this study was to investigate the natural history of ASD size in patients with a PDA following transcatheter PDA occlusion. Methods. All patients with an ASD and a PDA who underwent transcatheter PDA occlusion at Texas Children’s Hospital were identified. Patients with ASD diameter <3 mm, or additional cardiac defects were excluded. Eight patients (7 females) with small‐ to moderate‐sized ASDs and a PDA were identified. Patient demographics, echocardiographic data, and cardiac catheterization data were recorded. Data were analyzed by 1‐tailed t‐test. Results. Following PDA occlusion, ASD diameter decreased in 6 of 8 patients by a mean of 3.8 mm (±2.3 mm), including 2 that closed. The median duration of follow‐up was 689 days. One ASD remained unchanged and 1 increased in size. The mean maximum ASD diameter decreased from 6.4 mm (±2.2 mm) to 3.9 mm (±3.4 mm) (P = .03). Two patients underwent subsequent transcatheter ASD occlusion. Conclusion. Following transcatheter PDA occlusion, small‐ to moderate‐sized ASDs have significant probability to decrease in size, and possibly close. In infants and children, we recommend transcatheter PDA occlusion, and serial follow‐up of the size of the ASD. This will allow many small‐ to moderate‐sized ASDs to either close, or become smaller, obviating the need for future intervention. 相似文献
4.
Harvey A. Siegal PhD ; Paul J. Draus PhD ; Robert G. Carlson PhD ; Russel S. Falck MA ; Jichuan Wang PhD 《The Journal of rural health》2006,22(2):169-173
CONTEXT: Although the nonmedical use of stimulant drugs such as cocaine and methamphetamine is increasingly common in many rural areas of the United States, little is known about the health beliefs of people who use these drugs. PURPOSE: This research describes illicit stimulant drug users' views on health and health-related concepts that may affect their utilization of health care services. METHODS: A respondent-driven sampling plan was used to recruit 249 not-in-treatment, nonmedical stimulant drug users who were residing in 3 rural counties in west central Ohio. A structured questionnaire administered by trained interviewers was used to collect information on a range of topics, including current drug use, self-reported health status, perceived need for substance abuse treatment, and beliefs about health and health services. FINDINGS: Participants reported using a wide variety of drugs nonmedically, some by injection. Alcohol and marijuana were the most commonly used drugs in the 30 days prior to the interview. Powder cocaine was used by 72.3% of the sample, crack by 68.3%, and methamphetamine by 29.7%. Fair or poor health status was reported by 41.3% of the participants. Only 20.9% of the sample felt they needed drug abuse treatment. Less than one third of the sample reported that they would feel comfortable talking to a physician about their drug use, and 65.1% said they preferred taking care of their problems without getting professional help. CONCLUSIONS: Stimulant drug users in rural Ohio are involved with a range of substances and hold health beliefs that may impede health services utilization. 相似文献
5.
Robin L. Bissinger MSN RNC NNP Cheryl A. Carlson MS RNC NNP 《Newborn and Infant Nursing Reviews》2006,6(2):87
Surfactant, a complex substance containing specific proteins and phospholipids, is essential for gas exchange in the lungs. Research shows that surfactant not only lowers surface tension, but also plays a role in host defense. Surfactant replacement therapy is a cornerstone in the treatment of respiratory distress syndrome in premature infants. New information on endogenous surfactant composition including surfactant apoproteins has led to advances in the surfactant replacement products currently available. Because of the success of surfactant deficiency treatment in neonates, surfactant replacement therapy has been studied in both the pediatric and adult population for the treatment of other respiratory disorders. This article describes the composition, metabolism, and function of endogenous surfactant and other uses of surfactant replacement therapies in neonates. 相似文献
6.
7.
8.
Unfractionated cytokines have been shown to induce in vitro proliferation of neonatal rat Schwann cells but the nature of the mitogen(s) is not known. A mixture of rabbit antibodies specific for recombinant interleukin-1α (IL-1α) and interleukin-1β (IL-1β) inhibited Schwann cell proliferation induced by unfractionated human cytokines whereas antibodies to interleukin-2 (IL-2) and control IgG did not. However, purified human IL-1 and recombinant human IL-1α or β did not induce Schwann cell proliferation on their own. 相似文献
9.
10.